1. Home
  2. XOS vs LEXX Comparison

XOS vs LEXX Comparison

Compare XOS & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOS
  • LEXX
  • Stock Information
  • Founded
  • XOS 2016
  • LEXX 2004
  • Country
  • XOS United States
  • LEXX Canada
  • Employees
  • XOS N/A
  • LEXX N/A
  • Industry
  • XOS Construction/Ag Equipment/Trucks
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • XOS Consumer Discretionary
  • LEXX Health Care
  • Exchange
  • XOS Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • XOS 27.8M
  • LEXX 22.7M
  • IPO Year
  • XOS N/A
  • LEXX N/A
  • Fundamental
  • Price
  • XOS $2.40
  • LEXX $1.05
  • Analyst Decision
  • XOS Buy
  • LEXX Strong Buy
  • Analyst Count
  • XOS 2
  • LEXX 1
  • Target Price
  • XOS $6.00
  • LEXX $4.00
  • AVG Volume (30 Days)
  • XOS 30.9K
  • LEXX 254.4K
  • Earning Date
  • XOS 11-13-2025
  • LEXX 11-25-2025
  • Dividend Yield
  • XOS N/A
  • LEXX N/A
  • EPS Growth
  • XOS N/A
  • LEXX N/A
  • EPS
  • XOS N/A
  • LEXX N/A
  • Revenue
  • XOS $51,536,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • XOS $2.34
  • LEXX $46.98
  • Revenue Next Year
  • XOS $27.38
  • LEXX $17.26
  • P/E Ratio
  • XOS N/A
  • LEXX N/A
  • Revenue Growth
  • XOS N/A
  • LEXX 49.85
  • 52 Week Low
  • XOS $2.21
  • LEXX $0.77
  • 52 Week High
  • XOS $9.15
  • LEXX $2.85
  • Technical
  • Relative Strength Index (RSI)
  • XOS 33.36
  • LEXX 55.43
  • Support Level
  • XOS $2.60
  • LEXX $0.99
  • Resistance Level
  • XOS $2.87
  • LEXX $1.21
  • Average True Range (ATR)
  • XOS 0.11
  • LEXX 0.08
  • MACD
  • XOS -0.04
  • LEXX 0.02
  • Stochastic Oscillator
  • XOS 1.96
  • LEXX 52.04

About XOS Xos Inc.

Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Classes 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: